Diabetic kidney disease progression is associated with decreased lower-limb muscle mass and increased visceral fat area in T2DM patients

Aim This study aimed to explore the relationship between lower-limb muscle mass/visceral fat area and diabetic kidney disease (DKD) progression in patients with type 2 diabetes mellitus (T2DM). Methods A total of 879 participants with T2DM were divided into 4 groups according to the prognosis of CKD...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in endocrinology (Lausanne) Vol. 13; p. 1002118
Main Authors: Lin, Xiaopu, Chen, Zhenguo, Huang, Haishan, Zhong, Jingyi, Xu, Lingling
Format: Journal Article
Language:English
Published: Frontiers Media S.A 06-10-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim This study aimed to explore the relationship between lower-limb muscle mass/visceral fat area and diabetic kidney disease (DKD) progression in patients with type 2 diabetes mellitus (T2DM). Methods A total of 879 participants with T2DM were divided into 4 groups according to the prognosis of CKD classification from Kidney Disease: Improving Global Outcomes (KDIGO). Rectus femoris cross-sectional area (RFCSA) was measured through ultrasound, and visceral fat area (VFA) was evaluated with bioelectric impedance analysis (BIA). Results T2DM patients with high to very high prognostic risk of DKD showed a reduced RFCSA (male P < 0.001; female P < 0.05), and an enlarged VFA (male P < 0.05; female P < 0.05). The prognostic risk of DKD was negatively correlated with RFCSA ( P < 0.05), but positively correlated with VFA ( P < 0.05). Receiver-operating characteristic analysis revealed that the cutoff points of T2DM duration combined with RFCSA and VFA were as follows: (male: 7 years, 6.60 cm2, and 111 cm2; AUC = 0.82; 95% CI: 0.78–0.88; sensitivity, 78.0%; specificity, 68.6%, P < 0.001) (female: 9 years, 5.05 cm2, and 91 cm2; AUC = 0.73; 95% CI: 0.66–0.81; sensitivity, 73.9%; specificity, 63.3%, P < 0.001). Conclusion A significant association was demonstrated between reduced RFCSA/increased VFA and high- to very high-prognostic risk of DKD. T2DM duration, RFCSA, and VFA may be valuable markers of DKD progression in patients with T2DM. Clinical trial registration http://www.chictr.org.cn , identifier ChiCTR2100042214
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Leigh C Ward, The University of Queensland, Australia; Guido Gembillo, University of Messina, Italy; Jianping Liu, Second Affiliated Hospital of Nanchang University, China
These authors have contributed equally to this work
This article was submitted to Clinical Diabetes, a section of the journal Frontiers in Endocrinology
Edited by: Maria Margherita Rando, Agostino Gemelli University Polyclinic (IRCCS), Italy
ISSN:1664-2392
1664-2392
DOI:10.3389/fendo.2022.1002118